e.g. Tata motors, Reliance MF, 500570

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
 
Back to Company Page
Results:

Half yearly results in brief

(Rs crore)
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Sales 795.52 606.54 468.46 432.49 373.11
Operating profit 90.61 120.00 68.69 52.63 33.55
Interest 0.45 0.65 0.35 0.44 0.51
Gross profit 106.66 135.83 79.25 61.21 38.78
EPS (Rs) 10.65 42.49 21.09 15.76 8.88

Half yearly  results in details

Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Other income 16.50 16.48 10.91 9.01 5.74
Stock adjustment -158.83 -67.96 -12.28 15.53 -1.06
Raw material 123.00 57.88 35.65 49.30 40.31
Power and fuel - - - - -
Employee expenses 129.00 120.24 129.56 117.73 112.48
Excise - - - - -
Admin and selling expenses - - - -20.12 20.12
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 611.75 376.37 246.83 217.43 167.71
Provisions made - - - - -
Depreciation 13.23 7.47 7.88 7.91 9.04
Taxation 9.23 38.55 18.65 13.89 7.55
Net profit / loss 26.64 106.23 52.72 39.40 22.19
Extra ordinary item -57.56 16.43 - - -
Prior year adjustments - - - - -
Equity capital 5.00 5.00 5.00 5.00 5.00
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 11.39 19.79 14.66 12.17 8.99
GPM (%) 13.14 21.80 16.53 13.86 10.24
NPM (%) 3.28 17.05 11.00 8.92 5.86
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback